China's COVID-19 Vaccine is the world's first phase II clinical trial
14-04-2020
On April 12, the phase II human clinical trial of COVID-19 (adenoviral vector) vaccine developed in Wuhan. This is the world's first COVID-19 vaccine which enters Phase II human clinical trials. Diiferent with phase I, there are about 500 people in the trial. Volunteers do not need to receive 14 days of quarantine observation, just complete the safety observation by themselves.
Get the latest price? We'll respond as soon as possible(within 12 hours)